GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
A single, low dose of the NMDA receptor antagonist ketamine produces rapid antidepressant actions in treatment-resistant depressed patients. Understanding the cellular mechanisms underlying this will lead to new therapies for treating major depression. NMDARs are heteromultimeric complexes formed th...
Main Authors: | Oliver H Miller, Lingling Yang, Chih-Chieh Wang, Elizabeth A Hargroder, Yihui Zhang, Eric Delpire, Benjamin J Hall |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/03581 |
Similar Items
-
How ketamine helps to overcome depression
by: Thu N Huynh, et al.
Published: (2014-12-01) -
Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine
by: Soichiro Ide, et al.
Published: (2017-11-01) -
Ketamine may block NMDA receptors in astrocytescausing a rapid antidepressant effect
by: Bernhard J Mitterauer
Published: (2012-12-01) -
Regulation of Tau Protein on the Antidepressant Effects of Ketamine in the Chronic Unpredictable Mild Stress Model
by: Gehua Wen, et al.
Published: (2019-04-01) -
Co-agonists differentially tune GluN2B-NMDA receptor trafficking at hippocampal synapses
by: Joana S Ferreira, et al.
Published: (2017-06-01)